Saliva biomarker detection using an aptamer-based nanosensor

Wenjun Zhang; Sheyda Nazarian; Ming L. Wang

doi:10.1117/12.2298115

27 March 2018 Saliva biomarker detection using an aptamer-based nanosensor

Wenjun Zhang, Sheyda Nazarian, Ming L. Wang

Proceedings Volume 10598, Sensors and Smart Structures Technologies for Civil, Mechanical, and Aerospace Systems 2018; 105981E (2018) https://doi.org/10.1117/12.2298115
Event: SPIE Smart Structures and Materials + Nondestructive Evaluation and Health Monitoring, 2018, Denver, Colorado, United States

Abstract

Aptamers, with numerous advantages over antibodies, such as high stability, resistance to denaturation and degradation, and easy modification possibilities, have found widespread uses in biosensing, drug delivery, disease diagnosis and therapy. The specific binding ability of aptamers to cancer-related markers and cancer cells ensured high performance for early diagnosis of cancer. Carcinoembryonic antigen (CEA) usually is present only at very low levels in the blood of healthy adults, however, the levels can raise in certain kinds of cancers such as colon and rectal cancer, pancreas, breast, ovary or lung cancer, allowing CEA to be used as a tumor marker in clinical tests. Several research groups have further demonstrated the levels of CEA are significantly higher in saliva than in blood/serum. Here, we present an aptamer-based biosensor for CEA’s detection with a sensitivity of 0.399 µA/(ng/mL) in saliva. The binding affinities of the selected aptamers to CEA have been evaluated by Surface Plasmon Resonance imaging (SPRi) technology which is a very sensitive method to measure binding interactions of various biomolecules, including proteins, nucleic acids, and phospholipids. Furthermore, instead of using the time-consuming Systematic Evolution of Ligands by Exponential enrichment (SELEX) process, we proposed a molecular dynamics (MD) simulation method to automatically and effectively select target-specific aptamers. It systematically investigates the atomistic details of the binding mechanisms between aptamer and target. Complemented with experimental tests, SPRi validation and MD simulation, this electrochemical aptamer-based biosensing system demonstrates great sensitivity, clinically accuracy and reliability in realizing noninvasive disease detection and monitoring through saliva analysis.

Citation Download Citation

Wenjun Zhang, Sheyda Nazarian, and Ming L. Wang "Saliva biomarker detection using an aptamer-based nanosensor", Proc. SPIE 10598, Sensors and Smart Structures Technologies for Civil, Mechanical, and Aerospace Systems 2018, 105981E (27 March 2018); https://doi.org/10.1117/12.2298115

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available